Heart and Kidney Ketones Metabolism
Exogenous Ketone Salt on Heart and Kidney Ketone Metabolism Measured by Positron Emission Tomography
1 other identifier
interventional
10
1 country
1
Brief Summary
Participants will undergo 3 Positron Emission Tomography (PET) scans in 3 different conditions :
- 1.Fasting without exogenous ketone salt
- 2.Fasting with exogenous ketone salt supplement
- 3.Post-Prandial with exogenous ketone salt supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Oct 2020
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2023
CompletedJuly 19, 2023
July 1, 2023
1.8 years
July 7, 2020
July 18, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
11C-Acetoacetate Heart Ketone uptake
Heart ketone uptake measured by PET scan
60 minutes
11C-Acetoacetate Kidney ketone uptake
Kidney ketone uptake measured by PET scan
60 minutes
Cardiac Functions, telediastolic volume
telediastolic volume
60 minutes
Cardiac Functions, telesystolic volume
telesystolic volume
60 minutes
Cardiac functions, ejection fraction
Ejection fraction
60minutes
Secondary Outcomes (1)
Plasma ketone
60 minutes
Study Arms (3)
Control
NO INTERVENTIONFasting without exogenous ketone salt supplement
Fasting with exogenous ketone salt supplement
EXPERIMENTALFasting with exogenous ketone salt supplement
Post-Prandial with exogenous ketone salt supplement
EXPERIMENTALPost-Prandial with exogenous ketone salt supplement
Interventions
Participants will have to take 2 doses of supplement, one 75 minutes before the scan and one 30 minutes before the scan.
Participants will have to take 2 doses of supplement, one 75 minutes before the scan and one 30 minutes before the scan and they will have a liquid meal 20 minutes before the scan.
Eligibility Criteria
You may qualify if:
- Aged between 45 and 64
- Generally Healthy
- BMI between 18.5 and 27
You may not qualify if:
- All drugs taken on a daily basis
- Diabetes or pre-diabetes
- Digestive dysfunction
- Pregnancy or lactation
- Allergy to the supplement
- Participate in an intensive physical exercise training (more than three times a week)
- Being on a ketogenic diet or consumption of ketogenic supplement.
- More than 2 alcoholic beverages each day
- Any clinically significant anomaly in the blood profile
- Smoking
- Claustrophobia
- Being enrolled in another interventional research project or in a PET research project
- Unable to lie dorsally supine for at least 60 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Université de Sherbrookelead
- Société des Produits Nestlé (SPN)collaborator
Study Sites (1)
Rearsh Centre on Aging
Sherbrooke, Quebec, J1H4C4, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2020
First Posted
October 8, 2020
Study Start
October 15, 2020
Primary Completion
August 15, 2022
Study Completion
January 15, 2023
Last Updated
July 19, 2023
Record last verified: 2023-07